课题基金 / 基金详情

Identifying and characterizing essential genes and cancer driver genes in HNSCC using in vivo CRISPR screens.

Identifying and characterizing essential genes and cancer driver genes in HNSCC using in vivo CRISPR screens.
使用体内 CRISPR 筛选来识别和表征 HNSCC 中的必需基因和癌症驱动基因。
批准号：
478950
负责人：
Schramek Daniel
金额：
$77.47万
依托单位：
Sinai Health System (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478950&lang=en
关键词：
Crsirp-A Screen Head And Neck Squamous Cell Carcinoma In Vivo Crsipr Screen Single Cell And Spatial Transcriptomics

项目摘要

项目成果

Schramek Daniel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer research aims to identify genes that are essential for tumor cells to survive as it is the key to developing novel therapies that can combat cancer. Our focus is on Head & Neck Cancer, which is one of the deadliest and most prevalent cancers with l
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the molecular & cellular basis of Low-Grade Glioma
  • 批准号：
    478958
  • 项目类别：
    Operating Grants
  • 资助金额：
    $76.91万
  • 财政年份：
    2023
  • 负责人：
    Schramek Daniel
  • 依托单位：
    Sinai Health System (Toronto)
Identifying essential genes for epithelial homeostasis and KRas-driven carcinomas using in vivo CRISPR screens.
Deciphering the molecular & cellular basis of aggressive basal-like breast cancer
In vivo CRISPR screen to identify clinically relevant therapeutic targets for lung cancer
海外基金